Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV

PHASE4CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

December 12, 2022

Study Completion Date

December 12, 2022

Conditions
Chronic Inflammation
Interventions
DRUG

CBD oil

"* Each participant will be provided two 30mL(Milliliters) bottles (2000mg CBD per bottle) with a syringe dropper during their initial (baseline) visit with instructions to administer the solution under the tongue (0.5 cc \~1/2 dropper) twice per day (BID) 8-12 hours apart (morning and evening) at the prescribed daily dosage (63mg/day).~* The investigators plan to collect samples from five patients over three time points: baseline (no CBD), and after one and two months of CBD-administration"

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors
collaborator

Consortium for Medical Marijuana Clinical Outcomes Research

OTHER

lead

University of Florida

OTHER